The latest biotech news

News and Trends 5 Jul 2018

Series A Round Could Bring French Microbiome Treatment for Bowel Disease Into the Clinic

Netbiotix has raised €7.5M to bring its lead candidate for inflammatory bowel disease into clinical trials. The treatment uses a bacterium found in the gut to prevent and dampen inflammation. The company, based in Paris, develops treatments for inflammatory bowel disease (IBD) that consist of a single microbial strain that interacts with cells in the […]

July 5, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 4 Jul 2018

Stem Cells Could Help Patients Recover From Heart Attacks

Viscofan BioEngineering has a green light in Spain to start clinical testing for its stem cell technology in patients with weakened heart muscles after a heart attack. While Viscofan BioEngineering’s main focus is on making sausage casings out of collagen, its technology could also help patients with weak heart muscles after suffering from a heart […]

July 4, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 3 Jul 2018

French Lupus Vaccine Ready to Move Into Phase III

Neovacs, a French biotech, has shown its lupus vaccine can be effective in treating this severe autoimmune disease. Its lupus vaccine works by stimulating the patient’s immune system to produce antibodies against a protein called IFNα that regulates the immune system and is involved in the disease. The study enrolled 185 patients around the globe […]

July 3, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 2 Jul 2018

Dutch Snake Venom-Derived Clotting Agent Comes Closer to the Clinic

Dutch biotech raises €12.5M to complete the preclinical development of its lead compound for acute internal bleeding and bring the drug into clinical trials. VarmX, based in Leiden, the Netherlands, raised a Series A round of €7.5M led by BioGeneration Ventures, with an additional €5M provided by the Netherlands Enterprise Agency as an Innovation Credit. The […]

July 2, 2018 - 1 minutemin - By Alexander Burik

News and Trends 30 Jun 2018

Glass Microbiology: From the Microscope to the Art Gallery

Artist Luke Jerram is behind Glass Microbiology, a series of beautiful glass-blown microbes that are changing the way we perceive viruses and bacteria. We’ve all seen at some point brightly-colored illustrations of viruses, most likely the feared HIV or an alien-like bacteriophage. These representations feed our imagination and help us understand the tiny but complex world of […]

June 30, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 29 Jun 2018

Update: Yet Another ADC Company Makes Bank, This Time in Series B

Update (29.06.2018): NBE Therapeutics has extended its Series B fundraising round by 20M CHF (€17.3M), reaching a total of 40M CHF (€34.6M) for the round. Novo Holdings joins the Boehringer Ingelheim Venture Fund and the PPF Capital Partners Fund as a major shareholder of the Swiss biotech, which continues to develop its ADCs for improved […]

June 29, 2018 - 3 minutesmins - By Editorial Team

Duchenne muscular dystrophy Summit Therapeutics

News and Trends 28 Jun 2018

Muscular Dystrophy Drug Fails in Phase 2 Trial

The stock of Summit Therapeutics has plunged by 80% after announcing that its drug candidate for Duchenne muscular dystrophy failed to meet the primary and secondary endpoints of a Phase II clinical trial. Duchenne muscular dystrophy is a genetic disease that causes progressive muscle deterioration in children born with the disease. The British-American company Summit […]

June 28, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 27 Jun 2018

International Fund Raises €300M for Dementia Research

The Dementia Discovery Fund has raised $350M (€300M) to support industrial and academic scientists doing early-stage research to develop new dementia medicines. Launched in 2015, the Dementia Discovery Fund (DDF) is dedicated to investing in early-stage ventures that develop disease-modifying therapeutics for all types of dementia, including Alzheimer’s and Parkinson’s. Yesterday, the DDF completed a […]

June 27, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

gw pharmaceuticals fda epidiolex cannabinoid epilepsy

News and Trends 26 Jun 2018

Update: The FDA Approves First Cannabinoid Treatment for Epilepsy

Update (26/06/2018): The FDA has approved GW Pharmaceutical’s drug Epidiolex in two severe forms of epilepsy. The approval makes Epidolex the first prescription drug made from highly purified cannabidiol to reach the market. Published on 20/04/2018 GW Pharmaceuticals has received a unanimous recommendation from the FDA Advisory Committee Meeting supporting the approval of what could soon […]

June 26, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 25 Jun 2018

A Biodegradable Plaster Could Help us Treat Mouth Ulcers

British researchers and a Danish biotech have joined forces to develop a polymer patch that can treat mouth ulcer patients with long-term steroid release and make the wound-healing process faster. Dermtreat, based in Copenhagen, and researchers from the University of Sheffield’s School of Clinical Dentistry in the UK made a patch from polymers that stick […]

June 25, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 25 Jun 2018

Cambridge Biotech Raises €32M Series A Round to Treat Chronic Inflammation

NodThera raised £28M (€32M) in a Series A round co-led by Sofinnova Partners and 5AM Ventures to develop treatments for chronic inflammation. NodThera, based in Cambridge, UK, closed a substantial Series A financing round to develop its lead small molecule drug candidate to treat inflammatory diseases, as well as other drugs for neurodegenerative diseases and […]

June 25, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 25 Jun 2018

Update: Could Epigenetics Treat Alzheimer’s? A Spanish Biotech May Give Us Answers

Update (25/06/2018): Oryzon enrolls first patients in the UK in its clinical trial testing its epigenetic Alzheimer’s drug. The company plans to enroll a total of 90 patients in Spain, France and the UK. Update (14/05/2018): Oryzon has been given approval to expand to France its Phase IIa clinical trial for an epigenetic Alzheimer’s drug. The […]

June 25, 2018 - 3 minutesmins - By Alexander Burik

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Series A Round Could Bring French Microbiome Treatment for Bowel Disease Into the Clinic

Stem Cells Could Help Patients Recover From Heart Attacks

French Lupus Vaccine Ready to Move Into Phase III

Dutch Snake Venom-Derived Clotting Agent Comes Closer to the Clinic

Glass Microbiology: From the Microscope to the Art Gallery

Update: Yet Another ADC Company Makes Bank, This Time in Series B

Muscular Dystrophy Drug Fails in Phase 2 Trial

International Fund Raises €300M for Dementia Research

Update: The FDA Approves First Cannabinoid Treatment for Epilepsy

A Biodegradable Plaster Could Help us Treat Mouth Ulcers

Cambridge Biotech Raises €32M Series A Round to Treat Chronic Inflammation

Update: Could Epigenetics Treat Alzheimer’s? A Spanish Biotech May Give Us Answers

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!